TY - JOUR
T1 - The Transradial Approach to Percutaneous Coronary Intervention. Historical Perspective, Current Concepts, and Future Directions
AU - Rao, Sunil V.
AU - Cohen, Mauricio G.
AU - Kandzari, David E.
AU - Bertrand, Olivier F.
AU - Gilchrist, Ian C.
N1 - Funding Information:
Dr. Rao reports receiving funding from Terumo Medical , Portola Pharmaceuticals , Momenta Pharmaceuticals , and Cordis Corporation ; is a consultant for Terumo Medical; and consults and is on the Speakers' Bureaus for The Medicines Company, Bristol-Myers Squibb, and Sanofi-Aventis. Dr. Cohen reports receiving an honorarium for speaking at an event sponsored by Terumo Medical. Dr. Kandzari is a consultant for Abbott Vascular, Medtronic, Cordis, and Terumo Medical; and receives research grant funding from Medtronic , Abbott Vascular , and Cordis . Dr. Bertrand is supported by Cordis , Bristol-Myers Squibb/Sanofi-Aventis , and GE Healthcare . Dr. Gilchrist receives research contract support from AstraZeneca , Eisi Medical Research , Hoffman-LaRoche , Portola Pharmaceuticals , Boston Scientific , Angel Medical , Bristol-Myers Squibb , and Osiris Therapeutics Inc.
PY - 2010/5/18
Y1 - 2010/5/18
N2 - Periprocedural bleeding complications after percutaneous coronary intervention (PCI) are associated with increased short- and long-term morbidity and mortality. Although clinical trials have primarily assessed pharmacological strategies for reducing bleeding risk, there is a mounting body of evidence suggesting that adoption of a transradial rather than a transfemoral approach to PCI may permit greater reductions in bleeding risk than have been achieved with pharmacological strategies alone. However, despite a long history of use, a lack of widespread uptake by physicians coupled with the technological limitations of available devices has in the past confined transradial PCI to the status of a niche procedure, and many operators lack experience in this technique. In this review, we examine the history of the transradial approach to PCI and discuss some of the circumstances that have hitherto limited its appeal. We then review the current state of the peer-reviewed literature supporting its use and summarize the unresolved issues affecting broader application of this technique, including lack of operator familiarity and an insufficient evidence base for guiding practice. Finally, we describe potential directions for future investigation in the transradial realm.
AB - Periprocedural bleeding complications after percutaneous coronary intervention (PCI) are associated with increased short- and long-term morbidity and mortality. Although clinical trials have primarily assessed pharmacological strategies for reducing bleeding risk, there is a mounting body of evidence suggesting that adoption of a transradial rather than a transfemoral approach to PCI may permit greater reductions in bleeding risk than have been achieved with pharmacological strategies alone. However, despite a long history of use, a lack of widespread uptake by physicians coupled with the technological limitations of available devices has in the past confined transradial PCI to the status of a niche procedure, and many operators lack experience in this technique. In this review, we examine the history of the transradial approach to PCI and discuss some of the circumstances that have hitherto limited its appeal. We then review the current state of the peer-reviewed literature supporting its use and summarize the unresolved issues affecting broader application of this technique, including lack of operator familiarity and an insufficient evidence base for guiding practice. Finally, we describe potential directions for future investigation in the transradial realm.
UR - http://www.scopus.com/inward/record.url?scp=77951896808&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77951896808&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2010.01.039
DO - 10.1016/j.jacc.2010.01.039
M3 - Review article
C2 - 20466199
AN - SCOPUS:77951896808
SN - 0735-1097
VL - 55
SP - 2187
EP - 2195
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 20
ER -